TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Studies from Baylor College of Medicine, College of Medicine describe new findings in tuberculosis
September 9th, 2008
According to recent research from the United States, "Chronic immunosuppression is a known risk factor for allowing latent tuberculosis (TB) infection to transform into active TB. Immunosuppressive/immunomodulatory therapies, while highly efficacious in the treatment of psoriasis and psoriatic arthritis, may be associated with an increased rate of active TB in patients receiving some of these therapies." "Our aim was to arrive at a consensus on screening for latent TB infection in psoriasis patient treated with systemic and biologic agents. Reports in the literature were reviewed regarding immunosuppressive therapies and risk of TB. Screening patients for latent TB...
Source: TB & Outbreaks Week (2008-09-09)
|
